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INTRODUCTION
Eleven years have passed since Lehmann 1\ reported on paraaminosalicylic
acid (PAS), and it has been accepted firmly as a useful therapeutic agent in
the treatment of tuberculosis, but the effect of the oral administration of 10 Gm.
of PAS per day is considerably inferior in comparison to that of the injection
of 1 Gm. of streptomycin per day. Even with this dose, PAS causes loss of
appetite in a significant number of patients, and for this reason, it is difficult
to increase the dose.
Consequently, the parenteral administration of PAS has become an important
problem. Along this line in foreign reports, the present authors find Fisher,
Roberts and Hirrshaw.?' Paraf ,>' Lowenstein and Rockstroh" who attempted the
subcutaneous administration, and Regli and Staubli ,": Bogeri.?' Bar-kley," Tulon
and Pellerat,": Paraf,": Hinshaw and others '?' who attempted the intravenous
administration. Every method attempted by those investigators was merely the
injection of large volume of 2 to 3 per cent solution which may be impractical
in the therapy of chronic tuberculosis.
Early in 1951, an attempt was made in this laboratory to establish a practi-
cable method of the intravenous administration of a high concentration of PAS
and it was confirmed that 4 Gm. of PAS could be given intravenously in 10 per
cent solution without causing any considerable reactions by employing a sterile
powder of sodium salt of PAS which was highly purified by some cooperating
pharmaceutical companies, and was dissolved in distilled water at use. The
results were compiled, and reported at The Commemorative Lecture on the
Tenth Anniversary of the Foundation of the Tuberculosis Research Institute,
Kyoto University on June 16, 1951. Reports were successively submitted to The
Annual Reports of the Tuberculosis Research Institute, Kyoto University, Vol.
3, Shindan-To-Chiryo, 11) Shinryo-No-Hssai ;':" Reports of the Tuberculosis Re-
search Institute, Kyoto University, Vol. 2, No. 3 and various other publications.
About the same time, reports by Nakamura;':" Kanda, W Shinoi, I,,) Nakao;':"
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Tomizawa'": and Fujita ''" on the intravenous administration of a high concen-
tration of PAS began to appear in this country, but in foreign countries almost
no report is available on this subject up to the present day.
The present authors have continued with the study, and now with to proper-
ly arrange the results in order to ask for criticism by the readers concerned.
Comparison of the Transitions of the Concentrations of PAS in the
Blood After the Oral Administration with Those After
the Intravenous Administration.
The progressive changes of the concentrations of PAS in the blood obtained
after administration of 4 Gm. of the drug in a human body at a time by the
oral route was compared with those obtained by the intravenous route. For the
quantitative determination, the method of Klyne and Newhouse"? was employed.
(I) Concentrations of PAS in the Blood After Intravenous Administration.
The successive transitions of the concentrations of PAS in the blood after
intravenous administration of 4 Gm. of the drug are shown in Fig. 1. Although
individual variations according to such as the body weight were noted, the peak
concentrations which indicated 12 mg. to 29.5 mg. per dl. were obtained 30 mi-
nutes after the administration. The concentrations then gradually decreased as
follows: 6.5 mg. to 19.5 mg. per dl. after 1 hour, 5 mg. to 12 mg. per dl. after
2 hours, 4 mg. to 10 mg. per dl. after 4 hours, 2 mg. to 6.25 mg. per dl. after 6
hours and 0.2 mg. to 2 mg. per dl. 8 hours after the administration.
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Fig. 2.
(II) Concentrations of PAS in the Blood After Oral Administration.
Fig. 2 shows the successive transitions of the concentrations of PAS in the
blood after oral administration. As may be seen the concentrations were 6 mg.
to 8 mg. per dl. after 30 minutes, 10 mg. to 12.5 mg. per dl. after 1 hour, 5 mg.
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to 9 mg. per dl. after 2 hours, 1.75 mg. to 4.5 mg. per dl. after 4 hours, 1 mg.
to 2 mg. per dl. after 6 hours and 0.5 mg. to 1 mg. per dl. 8 hours after the
administration. In short, the peak values were found 1 hour after the oral
administration and a gradual descent of the values followed, however, a measur-
able concentration did not disappear even after 8 hours.
(III) Comparison of the Concentrations of PAS in the Blood After the
Intravenous Administration with Those After the Oral Administration
in the Same Individual.
Comparison of the blood PAS concentrations following the administration by
intravenous route with those by oral route in the same individual is shown in
Fig. 3, 4 and 5. In Fig. 3 and 5, the variation between the concentrations by
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those two routes was remarkable,
and not only after 30 minutes but
even 6 hours after the administra-
tion, the concentrations obtained by
using the intravenous route were
higher than those obtained by using
the oral route. Particularly in Fig.
3, the concentrations obtained by
intravenous administration were
higher even after 8 hours. In Fig. 4,
the variation between the concen-
trations following the intravenous
administration and those folIoing the oral administration was not remakable
throughout the experiments except after 30 minutes, but the former was slightly
higher even after 8 hours.
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As may be seen from the results of the experiments the peak concentrations
of PAS in the blood obtained after the administration of 4 Gm. of the drug by
the intravenous route are markedly higher than those by the oral route, however,
the concentrations obtained by using intravenous route are almost equal to those
obtained by using oral route 8 hours after the administration.
(IV) Transitions of the Quantity of the Bacteriostatic Substance in the
Blood After the Administration of PAS by Oral Route and by
Intravenous Route.
Although in the preceding experiments the blood concentrations of P-:\S were
measured by quantitative chemical analysis, it is questionable whether all the
substances reacted as PAS had possessed bacteriostatic activity. It is feared that
the PAS derivatives which lost some of their bacteriostatic activity by chemical
changes in the living body also reacted together as PAS, while it may be more
important for clinicians to know the quantity of bacteriostatic substance in the
body than to know the quantity of the substances which merely present a
definite chemical reaction.
The surum of the PAS administered subjects was obtained at different inter-
vals ; Kirchner's medium which contains the serum in the concentration of 90
per cent was prepared ; the growth of human type tubercle bacilli cultured in
this medium was observed ; and the durations of the bacter-iostatic activity
following oral administration and those following intravenous administration
were compared.




The sera were separated routinely from the blood drawn 4, 5, 6, 7 and 8
houres after the administration of 4 Gm. of PAS by intravenous route and by
oral route.
(2) Culture Medium
A modified Kirchner's synthetic medium was employed in this study. The
composition was as follows : Disodium phosphate, 3.0 gm. ; Monopotassium
phosphate, 4.0 gm. ; Magnesium sulfate, 0.6 gm. ; Sodium citrate, 2.5 grn. ; Aspa-
ragine, 5.0 gm. ; Glycerin 2).0 ml ; and Distilled water 100.0 ml. (The volume of
distilled water was only one-tenth of that used in standard Kirchner's medium.)
The pH was adjusted to 6.7 or 6.8. One part of this modified Kirchner's medium
was added to nine parts of the above described serum and was sterilized for
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60 minutes at 56"C water bath prior to using.
( 3) Inoculum
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Aoyarna-B strain and Frankfurt strain of tuber-cle bacilli cultured in the
Sauton's medium for 3 to 4 weeks were employed. In preparing the sus-
pension of tubercle becilli, one loop of the bacilli was transfered to 6.0 ml. of
Kirchner's medium containing several small glass-beads ; after 3 to 4 weeks
either 2.0 ml. of physiological saline solution or 2.0 ml. of Kirchner's synthetic
medium was added to this subculture; this was shaken for 5 minutes to break
up the aggregates of the bacilli into smaller clumps and even simgle bacilli ;
after allowing to remain for 20 minutes, 1.0 ml. of the supernatant was trans-
fused into another sterile test tube, and 4.0 ml. of physiological saline solution
or Kirchner's synthetic medium was, then, added. The preparation of the
suspension of bacilli was completed by shaking the tube again. For inoculation,
1 drop of this suspension was added to each culture tube.
(4) Determination
The bacteriostatic activity was determined by observing the existence and
the degree of the colonies in the bottoms of the culture tubes, comparing them
with the controls. The minimum inhibitory concentration was considered as
being the point where no macroscopic evidence of growth was found.
Results
The durations of the bacteriostatic activity following intravenous and oral
administration of 4 Gm. of PAS at several hours interval were determined in 4
subjects by employing above stated method.
As may be seen in Table 1, the bacteriostatic activity was demonstrated 5
hours after the oral administration of PAS, but it had disappeared after 6
hours. Following intravenous administration, it was maintained up to 6 hours
and disappeared at the 8 hour point.
In Table 2, the activity remained up to 5 hours after PAS orally, and
disappeard after 6 hours. Measurable activity remained up to 7 hours, and
disappeared 8 hours after intravenous administration.
'l'able 1 : (male, 54 kg.)
Hours Aftre Administration
Dose Route -"._--------
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Table 4 : (female, 45 kg.)
Hours After Administration
Do<:e Route
I4 5 6 7










# -I- Macroscopic evidence of growth was found
No evidence
In Table 3, the activity remained up to 5 hours, and disappeared 6 hours
after either intravenous or oral admipistration of PAS.
In Table 4, the same result as in Table 3 was obtained.
From these results, it was believed that the duration of bacteriostatic
activity of the serum following administration of PAS by the intravenous route
was longer than or, at least, equal to that by the oral route.
The Therapeutic Effect of PAS Given Intravenously in Tuberculous Patients
When this study was planned, it had been described in foreign reports that
injection of a large volume of PAS in 2 to 3 per cent solution over long period
of time was only the method of administering the drug intravenously without
cansing general or local toxic reactions. However, the present authors thought
that the biological action of a chemically unstable substance such as PAS might
be considerably influenced by its purity. The authors therefore, requested some
pharmaceutical companies to prepare a highly purified sterile power of PAS
Intravenous Administration of a High Concentration of PAS 7
enclosed in ampuls which may be used by dissolving in distilled water immedi-
ately before administration. From the results of this study, it was confirmed
that 4 Gm. of PAS in 10 per cent solution (40cc.) can be given intravenously
by ordinary methods.
(I) The Method of Intravenous Administration of Sodium PAS.
Powder of sodium PAS (in sterile ampules) dissolved in distilled water in
10 per cent solution was injected into the antecubital vein. Special attention
was paid to the time required for the injection which might influence the
appearance of the toxic reaction. In a dose of 4 Gm., sodium PAS was slowly
administered in 10 per cent solution, requiring more than 10 minutes for the
administration.
(II) Dosage.
A single dose of 4 Gm. of PAS was administered two or three times daily.
(III) Period of Injection.
Sixteen patients were treated for period of 3 weeks to 1 month and 7
patients were treated for 2 to 3 weeks.
(IV) Selection of Patients.
Most cases were selected f ro:n in-patients of the Tuberculosis Research
Institute, Kyoto University. The majority of the patients had chronic cavitary
tuberculosis and a few patients had intestinal tuberculosis.
(V) Clinical Results.
The clinical results which were based upon the essential points of "The
Plan of the Japanese Welfare Ministry's Antituberculous Therapy Research
Committee" were gathered. All 23 cases were recorded together. The clinical
results obtained one month after administration of oral PAS which were gathered
in accordance with the above-mentioned plan were shown in Table 6, to be
discussed in comparison with those after administration of intravenous PAS.
Brief explanations are described as follows.
(1) Fever
PAS given orally was considerably effective, but that given intravenously
showed more effectiveness. The temperatures in 80 per cent of 14 feverish
patients treated with intravenous PAS and 38 per cent of 16 patients treated
with oral PAS were reduced remarkable or slightly. The results indicate
evidently that intravenous administration of PAS is more effective than oral
administration. The elevated temperatures in patients treated with intravenous
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PAS fell markedly within a few days and the majority returned to nearly
normal level within 10 days, while the temperature elevations in the group
given PAS orally returned to normal level between 3 weeks and 30 days. The
reduction of fever caused by intravenous PAS may be compared with that ob-
tained by employing streptomycin. Two of the three patients with unchanged
high fevers died soon after.
(2) Appetite
As described in the introduction, the most important aim of the intravenous
administration of PAS attemted in this study is related to this clause. As
shown in Table 5, improvements were observed in 10 of the 16 patients with
loss of appetite, and in comparIson with the case in Table 6, intravenous
administration is superior to oral administration. As may be s=en in Table 7,
12 of the 13 patients treated with both intravenous and oral PAS separately,
mentioned that their appetites during the intravenous PAS treatment were
better than those during oral PAS treatment. This result may prove that PAS
given by the intravenous route disturbes appetite less than that by the oral
route, but, on the other hand, the improvement in appetite following PAS
intravenously may be due to the remarkable reduction of fever.
(3) Body-Weight
Three patients showed increase in weight. Reduction of fever and increase
of appetite may naturally cause weight increase but it seem to be inappropri-
ate to discuss weight increase since the treatment was of a duration of only
approximately one month.
(4) Sedimentation Rate of the Ery'thr-ocvtes
Marked improvement occurred in 3 patients.
(5) Cough
Out of 12 patients, 50 per cent showed improvement. There was little
difference between the results obtained by PAS administered intravenously and
those by oral administration of PAS.
(6) Expectoration
Decrease of the amount of sputum was observed in 7 patients. In a great part
of the patients, the effect of PAS appeared within a few days after intravenous
administration, keeping pace with above described improvement in cough. As
the amount of sputum decreased, the color of sputum turned from yellow to
yellowish white. There was no marked difference between the results following
administration of oral PAS and those following administration of intravenous PAS.
Intravenous Administration of a High Concentration of PAS
( 7 ) Tubercle Bacilli in Sputum
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In 7 patients (39 per ent), favorable results were obtained. No remarkble
difference was seen between the effect of intravenous administration of PAS
and that of oral administration.
(8) Roentgenographic Evaluation
Slight improvement was demonstrated in 3 cases. This poor result might
be due to the short periods of treatment and a large number of chronic cavitary
cases.
(9) Chronic Diarrhea
In 4 of 6 patients with chronic diarrhea which was believed to be due to
intestinal tuberculosis, improvements were obtained. Marked improvement in
a patient whose diarrhea had continued for over a year was included. The
results may indicate that intravenous PAS is effective in the treatment of
intestinal tuberculosis. The superiority of intravenous administration of PAS
to oral administration is evidenced by comparing Tables 5 and 6. Most of these
improvements appeared within several days after start of treatment.
Table 5 : Clinical results obtained by intravenous RAS (23 cases)




markedly I slig htly normal abnorm a l slightly
Temperature 5 6 9 3 0 0 0
Appetite 3 7 6 6 1 0 0
Body Weight 3 0 3 14 0 0 3
E. S. R. 3 a 5 12 a a 3
Cough 0 6 11 6 0 0 0
Expectoration 1 6 4 12 0 a 0
Tubercle Bacilli 4 3 5 10 1 a 0
Roentgenograp- a 3 a 17 1 a 2hic Appearance
Chronic 3 1 17 2 0 a 0Diarrhea ~
----._ .._----_._~ -
(VI) Toxic Reaction.
Toxic reactions encountered in intravenous administration of PAS were
local vascular pain, nausea, vomiting, headache, sensation of ill-being, tinnitus,
dizziness and others. Most of them appeared during the injection.
In regards to the factors of those toxic reactions, the first problem may be
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Became Worse
, , I Uncertain



















Temperature 3 3 10 10 0
Appetite 0 6 3 16 1
Body Weight 2 5 1 12 1
E. S. R. 3 6 2 15 0
Cough 1 7 10 8 a
Expectoration a 8 2 15 1
Tubercle Bacilli i 7 2 3 14 a
Roentgenograp- I a a 0 26 ahic Appear-ance
Chronic a 1 21 4 aDiarrhea
Table 7 : Comparison between effect of intravenous PAS and
PAS on appeti tes
Intravenous administration







was more effective in
a
the individual variation. Probably any quality of PAS can produce the reactions
in a few patients who have abnormal sensitivities to the drug.
The second problem may be the quality of manufactured PAS. The sterile
powder of PAS in ampules may be the safest and most suitable, if it is dissolved
in distilled water at use. The solution of PAS may be colored by long-stand-
ing, and this colored solution cannot be employed. Injection of the colored
solution may cause the toxic reactions immediately.
Third, the time required for injection is important. In case that the toxic
reactions occur without above-mentioned factors, it may be due to the time
spent for injection. The injection should be given as slowly as possible in order
to prevent the reactions. Ten minutes should be required for the injection of
4Gm. of PAS in 10 per cent solution (40 cc.).
Thrombophlebitis, hematuria, albuminuria, hemorrhagic phenomenon and
hepatic disturbance were not observed.
(1) The peak concentrations of PAS in the blood after the intravenous
administration is naturally higher than those after oral administration, and
moreover, the concentrations obtained by PAS intravenously and orally are
equal even 8 hours after the administrations.
(2) The bacteriostatic substance in the blood following PAS administered
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intravenously remains longer than those following PAS administered orally.
(3) PAS can be given intravenously in 40 cc. of 10 per cent solution.
(4) Clinical effect of PAS given intravenously is more marked than that of
PAS given orally.
(5) Intravenous administration of PAS will not cause any considerable
toxic reaction, if the injection is given over a period of longer than 10 minutes.
(Notice: The PAS employed on the present study was supplied by Tanabe
Seiyaku, Takeda Yakko, Daiichi Seiyaku, Fujisawa Yakko and Sumitomo
Kagaku. )
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